Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Shares Issued
Ratios

Atea Pharmaceuticals (AVIR) Leases (2021 - 2022)

Atea Pharmaceuticals has reported Leases over the past 2 years, most recently at $2.5 million for Q3 2022.

  • Quarterly results put Leases at $2.5 million for Q3 2022, up 1012.78% from a year ago — trailing twelve months through Sep 2022 was $2.5 million (up 1012.78% YoY), and the annual figure for FY2021 was $161000.0, changed.
  • Leases for Q3 2022 was $2.5 million at Atea Pharmaceuticals, down from $2.7 million in the prior quarter.
  • Over the last five years, Leases for AVIR hit a ceiling of $2.9 million in Q1 2022 and a floor of $161000.0 in Q4 2021.